Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Floyd

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Plos Medicine|September 14, 2006
Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the PhilippinesThelma E Tupasi, Rajesh Gupta, Ma Imelda D Quelapio, et al.
Lancet (London, England)|March 28, 2015
WHO's new end TB strategyMukund Uplekar, Diana Weil, Knut Lonnroth, et al.
Lancet (London, England)|May 22, 2012
Scaling up interventions to achieve global tuberculosis control: progress and new developmentsMario Raviglione, Ben Marais, Katherine Floyd, et al.
Bulletin of the World Health Organization|November 10, 2015
Cost-effectiveness of a comprehensive programme for drug-resistant tuberculosis in ChinaChristopher Fitzpatrick, Zhang Hui, Wang Lixia, et al.
The New England Journal of Medicine|September 15, 2016
Twenty Years of Global Surveillance of Antituberculosis-Drug ResistanceMatteo Zignol, Anna S Dean, Dennis Falzon, et al.
Plos Medicine|January 22, 2020
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional dataAnna S Dean, Matteo Zignol, Andrea Maurizio Cabibbe, et al.
The Lancet. Infectious Diseases|July 12, 2016
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance projectMatteo Zignol, Anna S Dean, Natavan Alikhanova, et al.
The Lancet. Infectious Diseases|March 26, 2018
Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance studyMatteo Zignol, Andrea Maurizio Cabibbe, Anna S Dean, et al.
Eclinicalmedicine|September 8, 2023
Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveysYohhei Hamada, Matteo Quartagno, Irwin Law, et al.
PLOS Global Public Health|February 29, 2024
Tobacco smoking clusters in households affected by tuberculosis in an individual participant data meta-analysis of national tuberculosis prevalence surveys: Time for household-wide interventions?Yohhei Hamada, Matteo Quartagno, Irwin Law, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Plos Medicine|September 14, 2006
Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the PhilippinesThelma E Tupasi, Rajesh Gupta, Ma Imelda D Quelapio, et al.
Lancet (London, England)|March 28, 2015
WHO's new end TB strategyMukund Uplekar, Diana Weil, Knut Lonnroth, et al.
Lancet (London, England)|May 22, 2012
Scaling up interventions to achieve global tuberculosis control: progress and new developmentsMario Raviglione, Ben Marais, Katherine Floyd, et al.
Bulletin of the World Health Organization|November 10, 2015
Cost-effectiveness of a comprehensive programme for drug-resistant tuberculosis in ChinaChristopher Fitzpatrick, Zhang Hui, Wang Lixia, et al.
The New England Journal of Medicine|September 15, 2016
Twenty Years of Global Surveillance of Antituberculosis-Drug ResistanceMatteo Zignol, Anna S Dean, Dennis Falzon, et al.
Plos Medicine|January 22, 2020
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional dataAnna S Dean, Matteo Zignol, Andrea Maurizio Cabibbe, et al.
The Lancet. Infectious Diseases|July 12, 2016
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance projectMatteo Zignol, Anna S Dean, Natavan Alikhanova, et al.
The Lancet. Infectious Diseases|March 26, 2018
Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance studyMatteo Zignol, Andrea Maurizio Cabibbe, Anna S Dean, et al.
Eclinicalmedicine|September 8, 2023
Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveysYohhei Hamada, Matteo Quartagno, Irwin Law, et al.
PLOS Global Public Health|February 29, 2024
Tobacco smoking clusters in households affected by tuberculosis in an individual participant data meta-analysis of national tuberculosis prevalence surveys: Time for household-wide interventions?Yohhei Hamada, Matteo Quartagno, Irwin Law, et al.
Pageof 8